Emergence and spread of antibiotic resistance following exposure to antibiotics
Abstract Within a susceptible wild-type population, a small fraction of cells, even <10−9, is not affected when challenged by an antimicrobial agent. This subpopulation has mutations that impede antimicrobial action, allowing their selection during clinical treatment. Emergence of resistance occu...
Saved in:
| Published in: | FEMS microbiology reviews Vol. 35; no. 5; pp. 977 - 991 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Oxford, UK
Blackwell Publishing Ltd
01-09-2011
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Abstract
Within a susceptible wild-type population, a small fraction of cells, even <10−9, is not affected when challenged by an antimicrobial agent. This subpopulation has mutations that impede antimicrobial action, allowing their selection during clinical treatment. Emergence of resistance occurs in the frame of a selective compartment termed a mutant selection window (MSW). The lower margin corresponds to the minimum inhibitory concentration of the susceptible cells, whereas the upper boundary, named the mutant prevention concentration (MPC), restricts the growth of the entire population, including that of the resistant mutants. By combining pharmacokinetic/pharmacodynamic concepts and an MPC strategy, the selection of resistant mutants can be limited. Early treatment avoiding an increase of the inoculum size as well as a regimen restricting the time within the MSW can reduce the probability of emergence of the resistant mutants. Physiological and, possibly, genetic adaptation in biofilms and a high proportion of mutator clones that may arise during chronic infections influence the emergence of resistant mutants. Moreover, a resistant population can emerge in a specific selective compartment after acquiring a resistance trait by horizontal gene transfer, but this may also be avoided to some extent when the MPC is reached. Known linkage between antimicrobial use and resistance should encourage actions for the design of antimicrobial treatment regimens that minimize the emergence of resistance.
Emergence of a resistant bacterial subpopulation within a susceptible wild-type population can be restricted with a regimen using an antibiotic dose that is sufficiently high to inhibit both susceptible and resistant bacteria. |
|---|---|
| AbstractList | Within a susceptible wild-type population, a small fraction of cells, even <10(-9) , is not affected when challenged by an antimicrobial agent. This subpopulation has mutations that impede antimicrobial action, allowing their selection during clinical treatment. Emergence of resistance occurs in the frame of a selective compartment termed a mutant selection window (MSW). The lower margin corresponds to the minimum inhibitory concentration of the susceptible cells, whereas the upper boundary, named the mutant prevention concentration (MPC), restricts the growth of the entire population, including that of the resistant mutants. By combining pharmacokinetic/pharmacodynamic concepts and an MPC strategy, the selection of resistant mutants can be limited. Early treatment avoiding an increase of the inoculum size as well as a regimen restricting the time within the MSW can reduce the probability of emergence of the resistant mutants. Physiological and, possibly, genetic adaptation in biofilms and a high proportion of mutator clones that may arise during chronic infections influence the emergence of resistant mutants. Moreover, a resistant population can emerge in a specific selective compartment after acquiring a resistance trait by horizontal gene transfer, but this may also be avoided to some extent when the MPC is reached. Known linkage between antimicrobial use and resistance should encourage actions for the design of antimicrobial treatment regimens that minimize the emergence of resistance. Emergence of a resistant bacterial subpopulation within a susceptible wild-type population can be restricted with a regimen using an antibiotic dose that is sufficiently high to inhibit both susceptible and resistant bacteria. Abstract Within a susceptible wild-type population, a small fraction of cells, even <10−9, is not affected when challenged by an antimicrobial agent. This subpopulation has mutations that impede antimicrobial action, allowing their selection during clinical treatment. Emergence of resistance occurs in the frame of a selective compartment termed a mutant selection window (MSW). The lower margin corresponds to the minimum inhibitory concentration of the susceptible cells, whereas the upper boundary, named the mutant prevention concentration (MPC), restricts the growth of the entire population, including that of the resistant mutants. By combining pharmacokinetic/pharmacodynamic concepts and an MPC strategy, the selection of resistant mutants can be limited. Early treatment avoiding an increase of the inoculum size as well as a regimen restricting the time within the MSW can reduce the probability of emergence of the resistant mutants. Physiological and, possibly, genetic adaptation in biofilms and a high proportion of mutator clones that may arise during chronic infections influence the emergence of resistant mutants. Moreover, a resistant population can emerge in a specific selective compartment after acquiring a resistance trait by horizontal gene transfer, but this may also be avoided to some extent when the MPC is reached. Known linkage between antimicrobial use and resistance should encourage actions for the design of antimicrobial treatment regimens that minimize the emergence of resistance. Emergence of a resistant bacterial subpopulation within a susceptible wild-type population can be restricted with a regimen using an antibiotic dose that is sufficiently high to inhibit both susceptible and resistant bacteria. Within a susceptible wild‐type population, a small fraction of cells, even <10−9, is not affected when challenged by an antimicrobial agent. This subpopulation has mutations that impede antimicrobial action, allowing their selection during clinical treatment. Emergence of resistance occurs in the frame of a selective compartment termed a mutant selection window (MSW). The lower margin corresponds to the minimum inhibitory concentration of the susceptible cells, whereas the upper boundary, named the mutant prevention concentration (MPC), restricts the growth of the entire population, including that of the resistant mutants. By combining pharmacokinetic/pharmacodynamic concepts and an MPC strategy, the selection of resistant mutants can be limited. Early treatment avoiding an increase of the inoculum size as well as a regimen restricting the time within the MSW can reduce the probability of emergence of the resistant mutants. Physiological and, possibly, genetic adaptation in biofilms and a high proportion of mutator clones that may arise during chronic infections influence the emergence of resistant mutants. Moreover, a resistant population can emerge in a specific selective compartment after acquiring a resistance trait by horizontal gene transfer, but this may also be avoided to some extent when the MPC is reached. Known linkage between antimicrobial use and resistance should encourage actions for the design of antimicrobial treatment regimens that minimize the emergence of resistance. Emergence of a resistant bacterial subpopulation within a susceptible wild‐type population can be restricted with a regimen using an antibiotic dose that is sufficiently high to inhibit both susceptible and resistant bacteria. Within a susceptible wild-type population, a small fraction of cells, even <10(-9) , is not affected when challenged by an antimicrobial agent. This subpopulation has mutations that impede antimicrobial action, allowing their selection during clinical treatment. Emergence of resistance occurs in the frame of a selective compartment termed a mutant selection window (MSW). The lower margin corresponds to the minimum inhibitory concentration of the susceptible cells, whereas the upper boundary, named the mutant prevention concentration (MPC), restricts the growth of the entire population, including that of the resistant mutants. By combining pharmacokinetic/pharmacodynamic concepts and an MPC strategy, the selection of resistant mutants can be limited. Early treatment avoiding an increase of the inoculum size as well as a regimen restricting the time within the MSW can reduce the probability of emergence of the resistant mutants. Physiological and, possibly, genetic adaptation in biofilms and a high proportion of mutator clones that may arise during chronic infections influence the emergence of resistant mutants. Moreover, a resistant population can emerge in a specific selective compartment after acquiring a resistance trait by horizontal gene transfer, but this may also be avoided to some extent when the MPC is reached. Known linkage between antimicrobial use and resistance should encourage actions for the design of antimicrobial treatment regimens that minimize the emergence of resistance. Emergence of a resistant bacterial subpopulation within a susceptible wild-type population can be restricted with a regimen using an antibiotic dose that is sufficiently high to inhibit both susceptible and resistant bacteria. Within a susceptible wild-type population, a small fraction of cells, even <10-9, is not affected when challenged by an antimicrobial agent. This subpopulation has mutations that impede antimicrobial action, allowing their selection during clinical treatment. Emergence of resistance occurs in the frame of a selective compartment termed a mutant selection window (MSW). The lower margin corresponds to the minimum inhibitory concentration of the susceptible cells, whereas the upper boundary, named the mutant prevention concentration (MPC), restricts the growth of the entire population, including that of the resistant mutants. By combining pharmacokinetic/pharmacodynamic concepts and an MPC strategy, the selection of resistant mutants can be limited. Early treatment avoiding an increase of the inoculum size as well as a regimen restricting the time within the MSW can reduce the probability of emergence of the resistant mutants. Physiological and, possibly, genetic adaptation in biofilms and a high proportion of mutator clones that may arise during chronic infections influence the emergence of resistant mutants. Moreover, a resistant population can emerge in a specific selective compartment after acquiring a resistance trait by horizontal gene transfer, but this may also be avoided to some extent when the MPC is reached. Known linkage between antimicrobial use and resistance should encourage actions for the design of antimicrobial treatment regimens that minimize the emergence of resistance. Emergence of a resistant bacterial subpopulation within a susceptible wild-type population can be restricted with a regimen using an antibiotic dose that is sufficiently high to inhibit both susceptible and resistant bacteria |
| Author | Cantón, Rafael Morosini, María-Isabel |
| Author_xml | – sequence: 1 givenname: Rafael surname: Cantón fullname: Cantón, Rafael email: rcanton.hrc@salud.madrid.org organization: Servicio de Microbiología and CIBER en Epidemiología y Salud Pública (CIBERESP), Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain – sequence: 2 givenname: María-Isabel surname: Morosini fullname: Morosini, María-Isabel organization: Servicio de Microbiología and CIBER en Epidemiología y Salud Pública (CIBERESP), Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21722146$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkF1LwzAUhoNM3If-BemdV61JmqQNeCPDqaAMRK9DbE9GR9fUpMXt35s6FUFEz00S8rznHJ4pGjW2AYQighMS6nydEJ6xWMhMJBQTkmBMJU-2B2jy9TFCE0xEHgvG-BhNvV9jjLnk_AiNKckoJUxM0PJqA24FTQGRbsrItw50GVkTXl31XNmuKiIHvvKdHhhj69q-Vs0qgm1rfe8g6uw31h-jQ6NrDycf5ww9La4e5zfx3fL6dn55Fxc87BDLTJZlylMuc1LSkpo8p4ILRrOiAAYsFBEYMomxwYVhWjIDXOeUpmmpTZrO0Nm-b-vsSw--U5vKF1DXugHbeyUxTQWTGfuTzHOcBU9iIPM9WTjrvQOjWldttNspgtXgXa3VoFcNetXgXb17V9sQPf0Y0j9voPwKfooOwMUeeK1q2P27sVrcP4RLiKf7uO3bX8Lxz63eAKFvoV4 |
| CitedBy_id | crossref_primary_10_1016_j_cej_2020_125498 crossref_primary_10_1097_FTD_0000000000000759 crossref_primary_10_1007_s00436_015_4423_1 crossref_primary_10_1093_cid_ciaa1309 crossref_primary_10_1128_AAC_01556_16 crossref_primary_10_1002_cbic_201800383 crossref_primary_10_1089_sur_2012_015 crossref_primary_10_1667_RR13853_1 crossref_primary_10_3390_antibiotics9030114 crossref_primary_10_1016_j_mib_2012_07_005 crossref_primary_10_1016_j_jhazmat_2017_08_067 crossref_primary_10_1016_j_jmaa_2016_07_028 crossref_primary_10_1089_mdr_2019_0287 crossref_primary_10_1016_j_rvsc_2019_08_022 crossref_primary_10_1016_j_scitotenv_2011_10_036 crossref_primary_10_7554_eLife_69511 crossref_primary_10_1007_s12088_019_00824_y crossref_primary_10_1021_acs_est_6b01794 crossref_primary_10_1016_j_cpme_2012_11_001 crossref_primary_10_1021_acsinfecdis_0c00024 crossref_primary_10_3109_1040841X_2013_875982 crossref_primary_10_1007_s40265_017_0787_0 crossref_primary_10_1128_AAC_02589_12 crossref_primary_10_1586_17512433_2015_1060124 crossref_primary_10_1186_s13023_014_0189_2 crossref_primary_10_1016_j_arcped_2016_06_002 crossref_primary_10_1080_14787210_2019_1573671 crossref_primary_10_3389_fmicb_2020_605962 crossref_primary_10_1016_j_arcped_2014_10_005 crossref_primary_10_1016_j_cmpb_2016_12_013 crossref_primary_10_1111_apm_12099 crossref_primary_10_3389_fmicb_2015_00588 crossref_primary_10_1155_2020_8853582 crossref_primary_10_1016_j_sajb_2017_05_027 crossref_primary_10_1128_AAC_02056_16 crossref_primary_10_1134_S0026261713010074 crossref_primary_10_2174_1568026622666220321124452 crossref_primary_10_1111_jam_12120 crossref_primary_10_1128_AAC_01504_20 crossref_primary_10_3389_fmicb_2017_00156 crossref_primary_10_4236_aid_2017_72006 crossref_primary_10_1371_journal_pone_0182863 crossref_primary_10_1371_journal_pone_0115223 crossref_primary_10_3390_ijerph10094274 crossref_primary_10_3389_fmicb_2022_971503 crossref_primary_10_1002_pro_3811 crossref_primary_10_1371_journal_pone_0041232 crossref_primary_10_1371_journal_pone_0106628 crossref_primary_10_51523_2708_6011_2017_14_3_7 crossref_primary_10_1016_j_coph_2011_07_007 crossref_primary_10_1016_j_animal_2022_100473 crossref_primary_10_1016_j_ijid_2023_11_023 crossref_primary_10_3390_ijms17101688 crossref_primary_10_1111_1574_6976_12062 crossref_primary_10_1155_2014_185068 crossref_primary_10_1016_j_envpol_2023_121185 crossref_primary_10_1016_j_jhazmat_2014_06_010 crossref_primary_10_1128_AAC_02135_13 crossref_primary_10_3389_fmicb_2018_01176 crossref_primary_10_1016_S2222_1808_14_60331_5 crossref_primary_10_1111_1462_2920_12028 crossref_primary_10_1016_j_puhe_2018_08_015 crossref_primary_10_1177_1098612X13504407 crossref_primary_10_3390_molecules22010029 crossref_primary_10_1093_jac_dkv442 crossref_primary_10_2217_fmb_13_28 crossref_primary_10_1093_femsre_fuab042 crossref_primary_10_1007_s12551_012_0071_1 crossref_primary_10_1111_eva_12136 crossref_primary_10_3390_antibiotics11111578 crossref_primary_10_1016_j_cmi_2017_12_004 crossref_primary_10_4155_fmc_12_213 crossref_primary_10_4236_abb_2022_133005 crossref_primary_10_1016_j_addr_2021_114078 crossref_primary_10_1038_s41579_021_00578_9 crossref_primary_10_1038_srep17968 crossref_primary_10_1016_j_eimc_2013_04_023 crossref_primary_10_1038_s41598_019_45886_6 crossref_primary_10_1186_s13756_020_0684_2 crossref_primary_10_3390_antibiotics10040463 crossref_primary_10_3390_gels9100826 crossref_primary_10_5897_AJMR2016_8283 crossref_primary_10_3390_pathogens10020165 crossref_primary_10_1093_femsle_fnaa019 crossref_primary_10_3390_antibiotics11111665 crossref_primary_10_2174_2211352521666230120100928 crossref_primary_10_1007_s00284_018_1498_9 crossref_primary_10_1155_2016_4152704 crossref_primary_10_1111_apt_14597 crossref_primary_10_1155_2023_6325568 crossref_primary_10_1371_journal_pone_0058389 crossref_primary_10_1111_j_1751_1097_2012_01139_x crossref_primary_10_22141_2312_413x_8_5_6_2020_217956 crossref_primary_10_1016_j_scitotenv_2024_170148 crossref_primary_10_1088_2632_959X_ad4c80 crossref_primary_10_1021_ac504880r crossref_primary_10_1007_s10646_017_1762_y crossref_primary_10_1146_annurev_anchem_091522_103827 crossref_primary_10_1016_j_cub_2014_03_036 crossref_primary_10_1016_j_scitotenv_2015_10_124 crossref_primary_10_1053_j_scrs_2014_05_014 crossref_primary_10_1038_ja_2017_41 crossref_primary_10_1080_14786419_2018_1474465 crossref_primary_10_4167_jbv_2019_49_3_95 crossref_primary_10_1016_j_envpol_2017_08_079 crossref_primary_10_1016_S1473_3099_13_70318_9 crossref_primary_10_3390_foods11203282 crossref_primary_10_1039_C2SM26828K crossref_primary_10_1016_j_tim_2015_01_005 crossref_primary_10_3390_microorganisms11010131 crossref_primary_10_1093_cid_ciae234 crossref_primary_10_1016_j_colsurfb_2020_111509 crossref_primary_10_1016_j_ijantimicag_2023_106913 crossref_primary_10_3109_03009734_2014_904457 crossref_primary_10_1016_j_ecoenv_2020_110767 crossref_primary_10_1038_s41598_022_13246_6 crossref_primary_10_1099_mgen_0_000972 crossref_primary_10_1371_journal_pone_0090448 crossref_primary_10_1016_j_diagmicrobio_2016_10_006 crossref_primary_10_1097_QCO_0000000000000940 crossref_primary_10_1038_s41598_020_74402_4 crossref_primary_10_1007_s40262_020_00981_0 crossref_primary_10_1093_femsle_fnab039 crossref_primary_10_1371_journal_pbio_3000713 crossref_primary_10_3923_pjbs_2021_1322_1332 crossref_primary_10_1016_j_drup_2012_03_005 crossref_primary_10_1016_j_micpath_2020_104028 crossref_primary_10_3390_antibiotics8010004 crossref_primary_10_1016_j_envpol_2024_123334 crossref_primary_10_1128_AAC_02180_20 crossref_primary_10_3390_antibiotics11050564 crossref_primary_10_1128_CMR_00101_15 crossref_primary_10_1111_jcpt_13277 crossref_primary_10_1016_j_plasmid_2014_01_002 crossref_primary_10_3389_fmicb_2016_00273 crossref_primary_10_3390_antibiotics12050872 crossref_primary_10_1099_jmm_0_050013_0 crossref_primary_10_3389_fmicb_2022_938676 crossref_primary_10_1016_j_cell_2014_06_046 crossref_primary_10_3389_fmicb_2015_00189 crossref_primary_10_4167_jbv_2019_49_4_176 crossref_primary_10_1002_ddr_21746 crossref_primary_10_1007_s00792_012_0475_7 crossref_primary_10_1016_j_jhazmat_2017_09_043 crossref_primary_10_3390_microorganisms6040125 crossref_primary_10_1371_journal_pcbi_1011364 crossref_primary_10_1016_S0213_005X_13_70126_5 crossref_primary_10_1016_j_jddst_2023_104894 crossref_primary_10_1016_j_jiph_2023_10_029 crossref_primary_10_3390_nano11071774 crossref_primary_10_1039_C5CS00041F crossref_primary_10_1007_s12011_020_02439_7 crossref_primary_10_1177_2041731414536573 crossref_primary_10_1016_j_jece_2024_113279 crossref_primary_10_1128_AAC_02495_18 crossref_primary_10_1016_j_sajb_2020_09_002 crossref_primary_10_1128_aac_01456_23 crossref_primary_10_1089_sur_2022_157 crossref_primary_10_1007_s11356_016_7699_5 crossref_primary_10_1128_AEM_00989_17 crossref_primary_10_1186_s13756_023_01219_x crossref_primary_10_1371_journal_pone_0141441 crossref_primary_10_1038_s41467_020_18336_5 crossref_primary_10_1128_AAC_02218_12 crossref_primary_10_1093_femsle_fny161 crossref_primary_10_3390_biology12040506 crossref_primary_10_1016_j_jtumed_2014_01_009 crossref_primary_10_1186_s13213_020_01552_1 crossref_primary_10_2807_1560_7917_ES_2018_23_47_1800081 crossref_primary_10_3390_antibiotics3010049 crossref_primary_10_1128_AAC_01982_17 crossref_primary_10_1016_j_fm_2014_03_019 crossref_primary_10_1186_s13756_020_00786_7 crossref_primary_10_4103_ijrc_ijrc_76_21 crossref_primary_10_1080_0972060X_2022_2132834 crossref_primary_10_1128_AAC_01858_20 crossref_primary_10_1371_journal_pcbi_1004689 crossref_primary_10_1093_emph_eoaa016 crossref_primary_10_1371_journal_pone_0211214 crossref_primary_10_1093_jac_dkx104 crossref_primary_10_3390_antibiotics10080929 crossref_primary_10_1371_journal_pone_0274174 crossref_primary_10_3390_diagnostics13152490 crossref_primary_10_1097_MRM_0000000000000142 crossref_primary_10_2174_1874285801408010006 crossref_primary_10_1007_s00248_016_0788_7 crossref_primary_10_3390_plants12183236 crossref_primary_10_1007_s00404_014_3484_1 crossref_primary_10_1016_j_jgar_2022_10_005 crossref_primary_10_1128_mBio_02073_16 crossref_primary_10_1016_j_chemosphere_2021_129713 crossref_primary_10_3389_fmicb_2020_01213 crossref_primary_10_3390_antibiotics5010003 crossref_primary_10_5662_wjm_v6_i2_143 crossref_primary_10_3390_antibiotics10101250 crossref_primary_10_1371_journal_pone_0281848 crossref_primary_10_1128_AAC_03505_14 crossref_primary_10_3389_fchem_2019_00265 crossref_primary_10_1016_j_heliyon_2023_e22368 crossref_primary_10_1128_mbio_03165_23 crossref_primary_10_2754_avb201584020083 crossref_primary_10_1080_17512433_2021_1901577 crossref_primary_10_1039_D3MD00143A crossref_primary_10_1016_j_jtice_2019_05_022 crossref_primary_10_3389_fmicb_2019_02740 crossref_primary_10_1093_femsle_fnz127 crossref_primary_10_1016_j_seppur_2022_120998 crossref_primary_10_1016_j_scitotenv_2023_167195 |
| Cites_doi | 10.1086/338639 10.1093/jac/dkq217 10.1093/jac/dkr053 10.1007/s00431-008-0901-0 10.1016/j.mib.2007.08.009 10.1093/jac/dkh242 10.1371/journal.ppat.1000735 10.1016/j.ijantimicag.2006.06.001 10.1016/j.ijantimicag.2009.11.003 10.1164/rccm.200401-070OC 10.1016/S0958-1669(03)00036-3 10.1128/JB.01081-08 10.1093/jac/dkg312 10.1093/jac/dkn260 10.1128/AAC.40.2.503 10.1016/j.ijantimicag.2009.12.011 10.1146/annurev.micro.112408.134306 10.1093/jac/dkh482 10.1128/AAC.44.8.2182-2184.2000 10.2174/092986708786848442 10.1128/AAC.00156-07 10.1128/CMR.15.4.647-679.2002 10.1086/516284 10.1111/j.1365-2958.2007.05642.x 10.1128/JB.00549-08 10.1016/j.diagmicrobio.2010.04.008 10.3201/eid1008.020694 10.1016/j.idc.2010.11.011 10.1128/CMR.15.2.167-193.2002 10.1128/AAC.47.3.1023-1027.2003 10.1099/mic.0.033993-0 10.1086/593186 10.1016/j.ijantimicag.2005.04.007 10.1007/978-1-59745-180-2_2 10.1586/14787210.6.5.725 10.1128/JCM.42.10.4769-4775.2004 10.1093/jac/dkn044 10.1128/AAC.45.2.433-438.2001 10.1128/AAC.44.9.2581-2584.2000 10.1128/JB.01581-07 10.1016/j.drup.2011.02.005 10.1111/j.1469-0691.2010.03317.x 10.1128/AAC.00736-05 10.1046/j.1365-2958.1999.01672.x 10.1093/jac/dkn357 10.1111/j.1469-0691.2006.01592.x 10.1016/S0924-8579(02)00028-6 10.1586/14787210.6.5.671 10.1093/jac/dkp387 10.1093/jac/dkl135 10.1093/jac/dkh393 10.1016/j.ijantimicag.2005.08.016 10.1016/j.ajic.2009.07.010 10.1086/422647 10.1101/cshperspect.a000398 10.1086/508752 10.1111/j.1365-2958.2006.05366.x 10.1016/j.ijantimicag.2008.06.031 10.1186/cc9062 10.1007/BF01716300 10.1128/AAC.00174-07 10.1128/JCM.01008-08 10.1128/AAC.01347-08 10.1128/AAC.00381-10 10.1111/j.1749-6632.2010.05788.x 10.1128/AAC.00358-09 10.1128/JB.01651-09 10.1093/jac/dkm186 10.1016/S0168-8278(99)80225-6 10.1086/600122 10.1128/AAC.00428-08 10.1038/nrmicro821 10.1002/bies.950190814 10.1016/S0140-6736(00)04519-0 10.1054/drup.2001.0196 10.1089/mdr.2010.0074 10.1111/j.1469-0691.2010.03250.x 10.1073/pnas.1018588108 10.1016/j.vetmic.2006.08.018 10.1016/j.tiv.2005.08.004 10.1086/653071 10.1111/j.1574-6976.2011.00289.x 10.1016/S1368-7646(03)00041-4 10.4161/viru.2.2.15014 10.1146/annurev-genet-102108-134805 10.1093/jac/dkr214 10.1128/AAC.00334-06 10.1086/430611 10.1093/jac/dkq496 10.1128/AAC.43.7.1756 10.1126/science.288.5469.1251 10.1111/j.1574-6968.2002.tb11452.x 10.1016/S0924-8579(10)70005-4 10.1128/AAC.01620-05 10.1111/j.1574-6976.2009.00165.x 10.1086/502304 10.1007/s00134-008-1355-6 10.1038/nrmicro909 10.1128/AAC.00927-10 10.1016/j.molcel.2010.01.003 10.1016/j.ijantimicag.2005.10.005 10.1179/joc.2005.17.5.484 10.1128/AAC.49.8.3382-3386.2005 10.1016/j.ijantimicag.2011.02.002 10.1128/AAC.00155-06 10.1056/NEJM199708143370701 10.1086/378810 10.1128/AAC.38.1.122 10.1093/jac/dkn229 10.1111/j.1469-0691.2010.03349.x 10.1128/CMR.00047-06 10.1126/science.1120800 10.1128/AAC.01444-06 10.1099/mic.0.26751-0 10.1128/AAC.01353-09 10.1086/648451 10.1016/j.diagmicrobio.2009.08.014 10.1097/00001432-200308000-00003 10.1086/598345 10.1128/AAC.44.9.2485-2491.2000 10.1128/AAC.01372-06 10.7326/0003-4819-119-5-199309010-00001 10.1111/j.1749-6632.2010.05867.x 10.1111/j.1469-0691.2005.01211.x |
| ContentType | Journal Article |
| Copyright | 2011 Federation of European Microbiological Societies. 2011 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved. |
| Copyright_xml | – notice: 2011 Federation of European Microbiological Societies. 2011 – notice: 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved – notice: 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7QL 7T7 8FD C1K FR3 P64 |
| DOI | 10.1111/j.1574-6976.2011.00295.x |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic Engineering Research Database Technology Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Bacteriology Abstracts (Microbiology B) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Engineering Research Database |
| Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| DocumentTitleAlternate | Antibiotic Resistance |
| EISSN | 1574-6976 |
| EndPage | 991 |
| ExternalDocumentID | 10_1111_j_1574_6976_2011_00295_x 21722146 FMR295 10.1111/j.1574-6976.2011.00295.x |
| Genre | article Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- -~X .3N .GA .Y3 05W 0R~ 10A 1OC 1TH 29H 31~ 36B 4.4 48X 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 88E 8CJ 8FE 8FH 8FI 8FJ 8UM 930 A03 A8Z AAHBH AAHHS AAIMJ AAMDB AAMVS AAOGV AAONW AAPQZ AAPXW AARHZ AASNB AAUQX AAVAP ABCQN ABEUO ABIXL ABJNI ABLJU ABPTD ABQLI ABUWG ABXVV ACCFJ ACFRR ACGFO ACGFS ACPRK ACUFI ACXQS ADBBV ADEZT ADGZP ADHKW ADHZD ADQBN ADRIX ADRTK ADVEK ADYVW ADZOD AEEZP AEGPL AEJOX AEKSI AELWJ AEMDU AENEX AENZO AEPUE AEQDE AETBJ AEWNT AFBPY AFFZL AFGWE AFIYH AFKRA AFOFC AFRAH AFXEN AFZJQ AGINJ AGSYK AHMBA AIWBW AJAOE AJBDE AJEEA AKRWK AKWXX ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ARIXL AVWKF AXUDD AYOIW AZBYB BAFTC BAYMD BBNVY BCRHZ BDRZF BENPR BEYMZ BHONS BHPHI BPHCQ BQDIO BSWAC BVXVI BY8 C45 CAG CDBKE COF CS3 D-E D-F D1J DAKXR DCZOG DILTD DR2 DU5 EBS EDH EJD EMB EMOBN ESTFP F00 F01 F04 F5P FDB FHSFR FLUFQ FOEOM FYUFA G-S G.N GAUVT GJXCC GODZA H.T H.X H13 HAR HCIFZ HF~ HMCUK HOLLA HZI HZ~ IX1 J0M J21 K48 KAQDR KBUDW KOP KSI KSN LC2 LC3 LH4 LK8 LP6 LP7 LW6 M1P M7P MK4 MM. N04 N05 N9A NF~ NLBLG NOMLY NVLIB O9- OAWHX ODMLO OIG OJQWA OK1 OVD P2P P2X P4D PAFKI PEELM PQQKQ PSQYO Q.N Q11 Q5Y QB0 R.K RIG ROL ROX ROZ RUSNO RX1 RXO SUPJJ SV3 TEORI TLC TOX UB1 UKHRP V8K W8V W99 WH7 WQJ WRC WYUIH XG1 YAYTL YKOAZ YXANX ZCN ZMT ~02 ~IA ~KM ~WT --K 1B1 1~5 3V. 4G. 7-5 AAEDT AAJQQ AALRI AAQFI AAQXK AAWDT AAXUO ABEFU ABMAC ABSAR ABSMQ ACBWZ ACIUM ACSCC ACUTJ ADMUD AFULF AFYAG AHEFC AI. ANFBD ASAOO ATDFG CCPQU CXTWN DC6 DFGAJ FEDTE FGOYB FIRID FZ0 HVGLF IAG IAO IEP IHE IHR ISR ITC LW9 M41 NQ- PROAC R2- RPM RPZ SEW SIN SSZ TCN VH1 XPP Y6R ZXP CGR CUY CVF ECM EIF NPM AAYXX ABEJV CITATION 7X8 7QL 7T7 8FD C1K FR3 P64 |
| ID | FETCH-LOGICAL-c5595-979dd3535981d2d2f882656427cce4e4444160e7900f0cf4a94fe5a82233daf33 |
| ISSN | 0168-6445 1574-6976 |
| IngestDate | Sat Oct 26 01:11:06 EDT 2024 Fri Oct 25 09:17:59 EDT 2024 Thu Nov 21 22:00:36 EST 2024 Tue Oct 15 23:43:24 EDT 2024 Sat Aug 24 00:54:38 EDT 2024 Wed Sep 11 04:52:20 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | mutant selection window resistant mutants β-lactam resistance quinolone resistance horizontal gene transfer mutant prevention concentration |
| Language | English |
| License | 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c5595-979dd3535981d2d2f882656427cce4e4444160e7900f0cf4a94fe5a82233daf33 |
| Notes | Editor: Dieter Haas ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 ObjectType-Article-1 ObjectType-Feature-2 |
| OpenAccessLink | https://academic.oup.com/femsre/article-pdf/35/5/977/18129407/35-5-977.pdf |
| PMID | 21722146 |
| PQID | 880716864 |
| PQPubID | 23479 |
| PageCount | 15 |
| ParticipantIDs | proquest_miscellaneous_902364974 proquest_miscellaneous_880716864 crossref_primary_10_1111_j_1574_6976_2011_00295_x pubmed_primary_21722146 wiley_primary_10_1111_j_1574_6976_2011_00295_x_FMR295 oup_primary_10_1111_j_1574-6976_2011_00295_x |
| PublicationCentury | 2000 |
| PublicationDate | 20110901 September 2011 2011-Sep 2011-09-00 |
| PublicationDateYYYYMMDD | 2011-09-01 |
| PublicationDate_xml | – month: 09 year: 2011 text: 20110901 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: England |
| PublicationTitle | FEMS microbiology reviews |
| PublicationTitleAlternate | FEMS Microbiol Rev |
| PublicationYear | 2011 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | 2008; 190 2002; 15 2005; 171 2010; 16 2010; 14 2002; 19 2004; 25 2011; 55 1999; 43 2008; 32 2004; 2 2003b 2001; 45 2003; 52 2010; 1213 2006; 20 2004; 39 2006; 27 1995; 23 2006; 28 2003; 47 2011; 66 2007; 60 2010; 192 2007; 64 2010; 2 2010; 6 2005; 192 2010; 31 2004; 42 2010; 38 1997; 337 2010; 37 2011; 2 2006; 50 2010; 36 2010; 35 2006; 57 1997 2003; 37 2006; 194 2007; 10 2007; 13 2004; 54 1993; 119 2009; 191 2004; 150 2008; 47 1999; 34 2008; 46 1999; 31 1998; 1 2005; 17 2005b; 26 2005; 11 2010; 54 2009; 43 2000; 44 2003; 14 2008; 6 2011; 14 2011; 17 2010; 66 2010; 65 2010; 64 2006; 62 2009; 53 2010; 68 2003; 6 2010; 156 1997; 19 2009; 200 2009; 168 1994; 38 2000; 288 2011; 25 2008; 61 2007; 20 2008; 62 1998; 26 2011 2010 2002; 34 2009 2003a; 16 2002; 217 2008; 15 2008; 13 2006 2007; 51 2011; 37 2001; 67 2005; 49 2006; 311 2004; 10 2009; 33 2005a; 26 2009; 35 2009; 30 2011; 108 2007; 119 2001; 4 1996; 40 2005; 55 2001; 357 Baquero (2016041923103206000_35.5.977.13) 1998; 1 2016041923103206000_35.5.977.95 2016041923103206000_35.5.977.94 2016041923103206000_35.5.977.11 2016041923103206000_35.5.977.99 2016041923103206000_35.5.977.98 2016041923103206000_35.5.977.96 2016041923103206000_35.5.977.15 2016041923103206000_35.5.977.14 2016041923103206000_35.5.977.12 2016041923103206000_35.5.977.19 2016041923103206000_35.5.977.18 2016041923103206000_35.5.977.17 2016041923103206000_35.5.977.16 Rodríguez-Rojas (2016041923103206000_35.5.977.111) 2009; 191 2016041923103206000_35.5.977.91 2016041923103206000_35.5.977.90 2016041923103206000_35.5.977.22 2016041923103206000_35.5.977.21 2016041923103206000_35.5.977.26 Dong (2016041923103206000_35.5.977.41) 1999; 43 2016041923103206000_35.5.977.23 Tam (2016041923103206000_35.5.977.119) 2005; 192 2016041923103206000_35.5.977.29 Cantón (2016041923103206000_35.5.977.27) 2006; 28 2016041923103206000_35.5.977.73 2016041923103206000_35.5.977.72 Baquero (2016041923103206000_35.5.977.8) 2001; 4 2016041923103206000_35.5.977.77 2016041923103206000_35.5.977.75 2016041923103206000_35.5.977.74 Hall-Stoodley (2016041923103206000_35.5.977.57) 2004; 2 2016041923103206000_35.5.977.79 Brown (2016041923103206000_35.5.977.24) 2005; 55 2016041923103206000_35.5.977.78 Bal (2016041923103206000_35.5.977.7) 2010; 1213 Craig (2016041923103206000_35.5.977.35) 1998; 26 Lepelletier (2016041923103206000_35.5.977.70) 2010; 66 Pallecchi (2016041923103206000_35.5.977.102) 2008; 6 Rahal (2016041923103206000_35.5.977.108) 2002; 34 Carratalà (2016041923103206000_35.5.977.28) 1996; 40 2016041923103206000_35.5.977.84 D'Costa (2016041923103206000_35.5.977.40) 2007; 10 2016041923103206000_35.5.977.82 2016041923103206000_35.5.977.81 2016041923103206000_35.5.977.88 2016041923103206000_35.5.977.86 2016041923103206000_35.5.977.85 López (2016041923103206000_35.5.977.76) 2007; 64 2016041923103206000_35.5.977.89 Mouton (2016041923103206000_35.5.977.92) 2002; 19 Firsov (2016041923103206000_35.5.977.51) 2004; 54 2016041923103206000_35.5.977.80 Baquero (2016041923103206000_35.5.977.10) 2011; 66 2016041923103206000_35.5.977.109 2016041923103206000_35.5.977.50 2016041923103206000_35.5.977.107 2016041923103206000_35.5.977.106 2016041923103206000_35.5.977.55 2016041923103206000_35.5.977.54 Aparicio (2016041923103206000_35.5.977.6) 1999; 31 2016041923103206000_35.5.977.59 Tam (2016041923103206000_35.5.977.120) 2007; 51 2016041923103206000_35.5.977.58 2016041923103206000_35.5.977.4 Valderrey (2016041923103206000_35.5.977.125) 2010; 68 2016041923103206000_35.5.977.3 2016041923103206000_35.5.977.56 2016041923103206000_35.5.977.2 2016041923103206000_35.5.977.1 Drlica (2016041923103206000_35.5.977.45) 2001; 67 Olofsson (2016041923103206000_35.5.977.101) 2006; 57 2016041923103206000_35.5.977.112 2016041923103206000_35.5.977.110 2016041923103206000_35.5.977.116 2016041923103206000_35.5.977.115 2016041923103206000_35.5.977.114 2016041923103206000_35.5.977.113 Ciofu (2016041923103206000_35.5.977.32) 2010; 156 2016041923103206000_35.5.977.62 2016041923103206000_35.5.977.61 2016041923103206000_35.5.977.60 Firsov (2016041923103206000_35.5.977.52) 2008; 32 2016041923103206000_35.5.977.66 2016041923103206000_35.5.977.64 2016041923103206000_35.5.977.63 Donlan (2016041923103206000_35.5.977.43) 2002; 15 2016041923103206000_35.5.977.69 2016041923103206000_35.5.977.68 2016041923103206000_35.5.977.67 Meyer (2016041923103206000_35.5.977.87) 2010; 14 Dong (2016041923103206000_35.5.977.42) 2000; 44 Novais (2016041923103206000_35.5.977.97) 2010; 6 Furtado (2016041923103206000_35.5.977.53) 2010; 31 Martínez (2016041923103206000_35.5.977.83) 2002; 15 2016041923103206000_35.5.977.100 2016041923103206000_35.5.977.105 2016041923103206000_35.5.977.103 Borg (2016041923103206000_35.5.977.20) 2008; 62 2016041923103206000_35.5.977.129 2016041923103206000_35.5.977.128 2016041923103206000_35.5.977.33 Levin (2016041923103206000_35.5.977.71) 2010; 54 2016041923103206000_35.5.977.31 Cantón (2016041923103206000_35.5.977.25) 2003; 16 2016041923103206000_35.5.977.30 Hsueh (2016041923103206000_35.5.977.65) 2005; 26 2016041923103206000_35.5.977.36 2016041923103206000_35.5.977.34 (2016041923103206000_35.5.977.5) 2008; 13 2016041923103206000_35.5.977.39 2016041923103206000_35.5.977.38 Sykes (2016041923103206000_35.5.977.118) 2010; 65 2016041923103206000_35.5.977.130 Croisier (2016041923103206000_35.5.977.37) 2004; 54 Peirano (2016041923103206000_35.5.977.104) 2010; 35 2016041923103206000_35.5.977.133 2016041923103206000_35.5.977.132 2016041923103206000_35.5.977.131 Mouton (2016041923103206000_35.5.977.93) 2011; 14 2016041923103206000_35.5.977.117 2016041923103206000_35.5.977.44 2016041923103206000_35.5.977.48 2016041923103206000_35.5.977.47 2016041923103206000_35.5.977.46 Baquero (2016041923103206000_35.5.977.9) 2004; 2 2016041923103206000_35.5.977.49 2016041923103206000_35.5.977.123 2016041923103206000_35.5.977.122 2016041923103206000_35.5.977.121 2016041923103206000_35.5.977.127 2016041923103206000_35.5.977.126 2016041923103206000_35.5.977.124 |
| References_xml | – year: 2011 – volume: 108 start-page: 1199 year: 2011 end-page: 1200 article-title: Evolving promiscuously publication-title: P Natl Acad Sci USA – volume: 53 start-page: 2483 year: 2009 end-page: 2491 article-title: Antibiotic resistance in strains with increased mutation frequency due to inactivation of the DNA oxidative repair system publication-title: Antimicrob Agents Ch – volume: 34 start-page: 1082 year: 1999 end-page: 1093 article-title: Quorum sensing in controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide publication-title: Mol Microbiol – volume: 1 start-page: 295 year: 1998 end-page: 300 article-title: Selection of very small differences in bacterial evolution publication-title: Int Microbiol – volume: 16 start-page: 315 year: 2003a end-page: 325 article-title: Multi‐resistant Gram‐negative bacilli publication-title: from epidemics to endemics – volume: 55 start-page: 1266 year: 2011 end-page: 1269 article-title: effect of , , and genes on fluoroquinolone activity against isogenic isolates with mutations in and publication-title: Antimicrob Agents Ch – volume: 53 start-page: 3411 year: 2009 end-page: 3415 article-title: Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in publication-title: Antimicrob Agents Ch – volume: 54 start-page: 178 year: 2004 end-page: 186 article-title: ABT492 and levofloxacin publication-title: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model – volume: 17 start-page: 484 year: 2005 end-page: 492 article-title: Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram‐negative urinary tract infection pathogens publication-title: J Chemother – volume: 171 start-page: 480 year: 2005 end-page: 487 article-title: Antibiotic rotation and development of gram‐negative antibiotic resistance publication-title: Am J Resp Crit Care – volume: 51 start-page: 2574 year: 2007 end-page: 2581 article-title: Influence of high mutation rates on the mechanisms and dynamics of and resistance development to single or combined antipseudomonal agents publication-title: Antimicrob Agents Ch – volume: 54 start-page: 3414 year: 2010 end-page: 3426 article-title: Population dynamics of antibiotic treatment publication-title: a mathematical model and hypotheses for time-kill and continuous-culture experiments – volume: 23 start-page: 316 year: 1995 end-page: 321 article-title: Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens publication-title: Infection – volume: 119 start-page: 353 year: 1993 end-page: 358 article-title: Nosocomial outbreak of infection resistant to late‐generation cephalosporins publication-title: Ann Intern Med – volume: 62 start-page: ii105 issue: (suppl 2) year: 2008 end-page: ii114 article-title: Clinical implications of antimicrobial resistance for therapy publication-title: J Antimicrob Chemoth – volume: 45 start-page: 433 year: 2001 end-page: 438 article-title: Mutant prevention concentrations of fluoroquinolones for clinical isolates of publication-title: Antimicrob Agents Ch – volume: 54 start-page: 673 year: 2010 end-page: 677 article-title: Comparative study of the mutant prevention concentrations of oxifloxacin, levofloxacin, and gemifloxacin against pneumococci publication-title: Antimicrob Agents Ch – volume: 30 start-page: 1180 year: 2009 end-page: 1185 article-title: Risk factors and clinical impact of carbapenemase‐producing publication-title: Infect Control Hosp Epidemiol – volume: 6 start-page: 137 year: 2003 end-page: 145 article-title: The role of mutators in the emergence of antibiotic‐resistant bacteria publication-title: Drug Resist Update – volume: 357 start-page: 1325 year: 2001 end-page: 1328 article-title: Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction publication-title: Lancet – volume: 66 start-page: 1161 year: 2011 end-page: 1167 article-title: Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended‐spectrum β‐lactamase‐producing publication-title: J Antimicrob Chemoth – volume: 35 start-page: 322 year: 2010 end-page: 332 article-title: Antibiotic resistance of bacterial biofilms publication-title: Int J Antimicrob Ag – volume: 51 start-page: 4163 year: 2007 end-page: 4166 article-title: Influence of inoculum size on the selection of resistant mutants of in relation to mutant prevention concentrations of marbofloxacin publication-title: Antimicrob Agents Ch – volume: 42 start-page: 4769 year: 2004 end-page: 4775 article-title: Dramatic increase in prevalence of fecal carriage of extended‐spectrum β‐lactamase‐producing Enterobacteriaceae during nonoutbreak situations in Spain publication-title: J Clin Microbiol – volume: 38 start-page: 122 year: 1994 end-page: 125 article-title: selective antibiotic concentrations of ß‐lactams for penicillin‐resistant populations publication-title: Antimicrob Agents Ch – volume: 168 start-page: 1181 year: 2009 end-page: 1187 article-title: Tetracycline‐resistant strains are inherited from parents and persist in the infant's intestines in the absence of selective pressure publication-title: Eur J Pediatr – volume: 2 start-page: a000398 year: 2010 article-title: Biofilms publication-title: Cold Spring Harb Perspect Biol – volume: 15 start-page: 647 year: 2002 end-page: 679 article-title: Interactions among strategies associated with bacterial infection publication-title: pathogenicity, epidemicity, and antibiotic resistance – year: 2003b – volume: 39 start-page: 497 year: 2004 end-page: 503 article-title: Predicting hospital rates of fluoroquinolone‐resistant from fluoroquinolone use in US hospitals and their surrounding communities publication-title: Clin Infect Dis – volume: 51 start-page: 2236 year: 2007 end-page: 2239 article-title: Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid‐carried quinolone resistance determinant publication-title: Antimicrob Agents Ch – volume: 190 start-page: 2767 year: 2008 end-page: 2776 article-title: growth rates and biofilm development of populations in chronic lung infection publication-title: J Bacteriol – volume: 64 start-page: 357 year: 2010 end-page: 372 article-title: Persister cells publication-title: Annu Rev Microbiol – volume: 10 start-page: 481 year: 2007 end-page: 489 article-title: Expanding the soil antibiotic resistome publication-title: exploring environmental diversity – volume: 27 start-page: 120 year: 2006 end-page: 124 article-title: Mutant prevention concentration for ciprofloxacin and levofloxacin with publication-title: Int J Antimicrob Ag – volume: 26 start-page: 43 year: 2005b end-page: 49 article-title: Nosocomial infections due to methicillin‐resistant and vancomycin‐resistant enterococci at a university hospital in Taiwan from 1991 to 2003 publication-title: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents – volume: 15 start-page: 3185 year: 2008 end-page: 3195 article-title: Prevention and treatment of biofilms publication-title: Curr Med Chem – volume: 51 start-page: 3810 year: 2007 end-page: 3815 article-title: Pharmacodynamic assessment based on mutant prevention concentrations of fluoroquinolones to prevent the emergence of resistant mutants of Streptococcus pneumoniae publication-title: Antimicrob Agents Ch – volume: 14 start-page: 255 year: 2003 end-page: 261 article-title: Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure publication-title: Curr Opin Biotech – volume: 65 start-page: 350 year: 2010 end-page: 360 article-title: Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use publication-title: J Antimicrob Chemoth – volume: 2 start-page: 510 year: 2004 end-page: 518 article-title: From pieces to patterns publication-title: evolutionary engineering in bacterial pathogens – volume: 66 start-page: 1659 year: 2011 end-page: 1672 article-title: The 2010 Garrod Lecture publication-title: the dimension of evolution in antibiotic resistance: ex unibus plurum et ex pluribus unum – volume: 13 start-page: 269 year: 2007 end-page: 276 article-title: Antimicrobial drug use and infection control practices associated with the prevalence of methicillin‐resistant s in European hospitals publication-title: Clin Microbiol Infec – volume: 51 start-page: 744 year: 2007 end-page: 747 article-title: The relationship between quinolone exposures and resistance amplification is characterized by an inverted U publication-title: a new paradigm for optimizing pharmacodynamics to counterselect resistance – volume: 66 start-page: 531 year: 2011 end-page: 538 article-title: Effect of inactivation on mutagenesis of exposed to sublethal concentrations of antimicrobials publication-title: J Antimicrob Chemoth – volume: 311 start-page: 374 year: 2006 end-page: 377 article-title: Sampling the antibiotic resistome publication-title: Science – volume: 35 start-page: 862 year: 2009 end-page: 870 article-title: Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant and in an ICU publication-title: Intens Care Med – volume: 1213 start-page: 92 year: 2010 end-page: 105 article-title: The interface between veterinary and human antibiotic use publication-title: Ann NY Acad Sci – volume: 20 start-page: 391 year: 2007 end-page: 408 article-title: Setting and revising antibacterial susceptibility breakpoints publication-title: Clin Microbiol Rev – volume: 19 start-page: 731 year: 1997 end-page: 736 article-title: Selective compartments for resistant microorganisms in antibiotic gradients publication-title: Bioessays – volume: 190 start-page: 5493 year: 2008 end-page: 5501 article-title: Hydrogen peroxide linked to lysine oxidase activity facilitates biofilm differentiation and dispersal in several Gram‐negative bacteria publication-title: J Bacteriol – volume: 65 start-page: 1842 year: 2010 end-page: 1852 article-title: The 2009 Garrod lecture publication-title: the evolution of antimicrobial resistance: a Darwinian perspective – volume: 16 start-page: 798 year: 2010 end-page: 808 article-title: Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance publication-title: Clin Microbiol Infec – volume: 38 start-page: 212 year: 2010 end-page: 216 article-title: Antibiotic consumption as a driver for resistance in and within a developing region publication-title: Am J Infect Control – volume: 28 start-page: S115 issue: (suppl 2) year: 2006 end-page: S127 article-title: Respiratory tract infections publication-title: at-risk patients, who are they? Implications for their management with levofloxacin – year: 2011 article-title: Persistence of antibiotic resistance in bacterial populations publication-title: FEMS Microbiol Rev – volume: 31 start-page: 664 year: 2010 end-page: 666 article-title: Correlation between rates of carbapenem consumption and the prevalence of carbapenem‐resistant in a tertiary care hospital in Brazil publication-title: a 4-year study – volume: 191 start-page: 44 year: 2009 end-page: 50 article-title: The gene plays an antimutator role and provides general stress protection publication-title: J Bacteriol – volume: 49 start-page: 3382 year: 2005 end-page: 3386 article-title: Hypermutation is a key factor in development of multiple‐antimicrobial resistance in strains causing chronic lung infections publication-title: Antimicrob Agents Ch – volume: 11 start-page: 750 year: 2005 end-page: 758 article-title: The selection of resistance to and the mutagenicity of different fluoroquinolones in and publication-title: Clin Microbiol Infec – volume: 1213 start-page: 81 year: 2010 end-page: 91 article-title: Antibiotic heterogeneity publication-title: from concept to practice – volume: 43 start-page: 167 year: 2009 end-page: 195 article-title: Gene amplification and adaptive evolution in bacteria publication-title: Annu Rev Genet – volume: 25 start-page: 245 year: 2011 end-page: 260 article-title: Antimicrobial stewardship publication-title: Infect Dis Clin N Am – volume: 66 start-page: 1 year: 2010 end-page: 6 article-title: Imipenem‐resistant gastrointestinal carriage among hospitalized patients publication-title: risk factors and resistance mechanisms – volume: 47 start-page: 1526 year: 2008 end-page: 1533 article-title: Chronic infection in chronic obstructive pulmonary disease publication-title: Clin Infect Dis – volume: 46 start-page: 2796 year: 2008 end-page: 2799 article-title: High rate of intestinal colonization with extended‐spectrum‐β‐lactamase‐producing organisms in household contacts of infected community patients publication-title: J Clin Microbiol – volume: 10 start-page: 1432 year: 2004 end-page: 1441 article-title: Antimicrobial drug use and methicillin‐resistant , Aberdeen, 1996–2000 publication-title: Emerg Infect Dis – volume: 194 start-page: 1601 year: 2006 end-page: 1608 article-title: The mutant selection window in rabbits infected with publication-title: J Infect Dis – volume: 288 start-page: 1251 year: 2000 end-page: 1254 article-title: High frequency of hypermutable in cystic fibrosis lung infection publication-title: Science – volume: 37 start-page: 581 year: 2011 end-page: 584 article-title: Correlation between fluoroquinolone consumption in hospitals and ciprofloxacin resistance amongst isolates causing healthcare‐associated infections, Taiwan, 2000–2009 publication-title: Int J Antimicrob Ag – volume: 156 start-page: 1108 year: 2010 end-page: 1119 article-title: Genetic adaptation of during chronic lung infection of patients with cystic fibrosis publication-title: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants – volume: 2 start-page: 144 year: 2011 end-page: 146 article-title: The intrinsic resistome of to β‐lactams publication-title: Virulence – volume: 68 start-page: 20 year: 2010 end-page: 27 article-title: Chronic colonization by of patients with obstructive lung diseases publication-title: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease – start-page: 9 year: 2009 end-page: 32 – volume: 44 start-page: 2485 year: 2000 end-page: 2491 article-title: Concentration‐dependent selection of small phenotypic differences in TEM beta‐lactamase‐mediated antibiotic resistance publication-title: Antimicrob Agents Chemother – volume: 40 start-page: 503 year: 1996 end-page: 505 article-title: Emergence of fluoroquinolone‐resistant in fecal flora of cancer patients receiving norfloxacin prophylaxis publication-title: Antimicrob Agents Ch – volume: 20 start-page: 342 year: 2006 end-page: 346 article-title: Mutagenesis induced by 12 quinolone antibacterial agents in WP2uvrA/pKM101 publication-title: Toxicol In Vitro – volume: 44 start-page: 2581 year: 2000 end-page: 2584 article-title: Mutant prevention concentration as a measure of antibiotic potency publication-title: studies with clinical isolates of Mycobacterium tuberculosis – volume: 54 start-page: 640 year: 2004 end-page: 647 article-title: pharmacodynamic efficacy of gatifloxacin against in an experimental model of pneumonia publication-title: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants – volume: 150 start-page: 1327 year: 2004 end-page: 1338 article-title: Emergence of phenotypic variants upon mismatch repair disruption in publication-title: Microbiology – volume: 62 start-page: 84 year: 2006 end-page: 99 article-title: PBP3 inhibition elicits adaptive responses in publication-title: Mol Microbiol – volume: 64 start-page: 83 year: 2007 end-page: 93 article-title: Antibiotic‐mediated recombination publication-title: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli – volume: 32 start-page: 488 year: 2008 end-page: 493 article-title: Enrichment of resistant at ciprofloxacin concentrations simulated within the mutant selection window publication-title: bolus versus continuous infusion – volume: 52 start-page: 145 year: 2003 end-page: 148 article-title: European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria publication-title: J Antimicrob Chemoth – volume: 50 start-page: 2695 year: 2006 end-page: 2699 article-title: Antibiotic coresistance in extended‐spectrum‐β‐lactamase‐producing Enterobacteriaceae and activity of tigecycline publication-title: Antimicrob Agents Ch – volume: 14 start-page: R113 year: 2010 article-title: Dramatic increase of third‐generation cephalosporin‐resistant in German intensive care units publication-title: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008 – volume: 217 start-page: 31 year: 2002 end-page: 35 article-title: Characterization of the GO system of publication-title: FEMS Microbiol Lett – volume: 36 start-page: S15 issue: (suppl 3) year: 2010 end-page: S8 article-title: Antibiotic heterogeneity publication-title: Int J Antimicrob Agents – start-page: 37 year: 2010 end-page: 45 – volume: 25 start-page: 832 year: 2004 end-page: 837 article-title: Reduced use of third‐generation cephalosporins decreases the acquisition of extended‐spectrum β‐lactamase‐producing publication-title: Infect Control Hosp Epidemiol – volume: 30 start-page: 786 year: 2009 end-page: 789 article-title: Vancomycin‐resistant enterococci in long‐term care facilities publication-title: Infect Control Hosp Epidemiol – volume: 33 start-page: 531 year: 2009 end-page: 538 article-title: Side effects of antibiotics on genetic variability publication-title: FEMS Microbiol Rev – volume: 62 start-page: 434 year: 2008 end-page: 436 article-title: A unified anti‐mutant dosing strategy publication-title: J Antimicrob Chemoth – volume: 13 start-page: 19035 year: 2008 article-title: Recent trends in antimicrobial resistance among and isolates publication-title: the French experience – volume: 55 start-page: 6 year: 2005 end-page: 9 article-title: Antibiotic cycling or rotation publication-title: a systematic review of the evidence of efficacy – volume: 17 start-page: 1 year: 2011 end-page: 5 article-title: Joint effects of topoisomerase alterations and plasmid‐mediated quinolone‐resistant determinants in enterica Typhimurium publication-title: Microb Drug Resist – volume: 26 start-page: 463 year: 2005a end-page: 472 article-title: Relationships between antimicrobial use and antimicrobial resistance in Gram‐negative bacteria causing nosocomial infections from 1991–2003 at a university hospital in Taiwan publication-title: Int J Antimicrob Ag – volume: 192 start-page: 420 year: 2005 end-page: 428 article-title: Bacterial‐population responses to drug‐selective pressure publication-title: examination of garenoxacin's effect on Pseudomonas aeruginosa – volume: 57 start-page: 1116 year: 2006 end-page: 1121 article-title: Selection of ciprofloxacin resistance in in an kinetic model publication-title: relation between drug exposure and mutant prevention concentration – volume: 119 start-page: 304 year: 2007 end-page: 310 article-title: Mutant prevention concentration of ciprofloxacin and enrofloxacin against and publication-title: Vet Microbiol – volume: 2 start-page: 95 year: 2004 end-page: 108 article-title: Bacterial biofilms publication-title: from the natural environment to infectious diseases – volume: 53 start-page: 3384 year: 2009 end-page: 3390 article-title: Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in by a quinolone in a mouse thigh bacterial infection model publication-title: Antimicrob Agents Ch – volume: 60 start-page: 263 year: 2007 end-page: 268 article-title: Transposon characterization of vancomycin‐resistant (VREF) and dissemination of resistance associated with transferable plasmids publication-title: J Antimicrob Chemoth – volume: 6 start-page: e1000735 year: 2010 article-title: Evolutionary trajectories of β‐lactamase CTX‐M‐1 cluster enzymes publication-title: predicting antibiotic resistance – volume: 337 start-page: 441 year: 1997 end-page: 446 article-title: The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance publication-title: New Engl J Med – volume: 37 start-page: 1201 year: 2003 end-page: 1209 article-title: Hypermutation as a factor contributing to the acquisition of antimicrobial resistance publication-title: Clin Infect Dis – volume: 17 year: 2011 article-title: Cephalosporin and fluoroquinolone combinations are highly associated with CTX‐M β‐lactamase‐producing publication-title: a case–control study in a French teaching hospital – volume: 67 start-page: 27 year: 2001 end-page: 33 article-title: A strategy for fighting antibiotic resistance publication-title: ASM News – volume: 19 start-page: 323 year: 2002 end-page: 331 article-title: Breakpoints publication-title: current practice and future perspectives – volume: 15 start-page: 167 year: 2002 end-page: 193 article-title: Biofilms publication-title: survival mechanisms of clinically relevant microorganisms – volume: 34 start-page: 499 year: 2002 end-page: 503 article-title: Nosocomial antibiotic resistance in multiple gram‐negative species publication-title: experience at one hospital with squeezing the resistance balloon at multiple sites – volume: 50 start-page: 2228 year: 2006 end-page: 30 article-title: Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin‐tazobactam, and tobramycin against publication-title: Antimicrob Agents Ch – volume: 6 start-page: 725 year: 2008 end-page: 732 article-title: Antibiotic resistance in the absence of antimicrobial use publication-title: mechanisms and implications – volume: 14 start-page: 107 year: 2011 end-page: 117 article-title: Conserving antibiotics for the future publication-title: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective – volume: 44 start-page: 2182 year: 2000 end-page: 2184 article-title: Selection of naturally occurring extended‐spectrum TEM β‐lactamase variants by fluctuating β‐lactam pressure publication-title: Antimicrob Agents Ch – volume: 6 start-page: 671 year: 2008 end-page: 683 article-title: Clinical significance of extended‐spectrum β‐lactamases publication-title: Expert Rev Anti Infect Ther – volume: 35 start-page: 316 year: 2010 end-page: 321 article-title: Molecular epidemiology of producing CTX‐M β‐lactamases publication-title: the worldwide emergence of clone ST131 O25:H4 – volume: 37 start-page: 311 year: 2010 end-page: 320 article-title: Sublethal antibiotic treatment leads to multidrug resistance via radical‐induced mutagenesis publication-title: Mol Cell – volume: 31 start-page: 277 year: 1999 end-page: 283 article-title: Development of quinolone‐resistant strains of in stools of patients with cirrhosis undergoing norfloxacin prophylaxis publication-title: clinical consequences – volume: 43 start-page: 1756 year: 1999 end-page: 1758 article-title: Effect of fluoroquinolone concentration on selection of resistant mutants of BCG and publication-title: Antimicrob Agents Ch – volume: 4 start-page: 93 year: 2001 end-page: 105 article-title: Low‐level antibacterial resistance publication-title: a gateway to clinical resistance – year: 2006 – volume: 200 start-page: 390 year: 2009 end-page: 398 article-title: Ciprofloxacin dosage and emergence of resistance in human commensal bacteria publication-title: J Infect Dis – volume: 61 start-page: 1053 year: 2008 end-page: 1056 article-title: Increased mutability of in biofilms publication-title: J Antimicrob Chemoth – volume: 192 start-page: 6191 year: 2010 end-page: 6199 article-title: Emergence of strains producing high levels of persister cells in patients with cystic fibrosis publication-title: J Bacteriol – volume: 50 start-page: 2957 year: 2006 end-page: 2965 article-title: Mechanism‐based pharmacodynamic models of fluoroquinolone resistance in publication-title: Antimicrob Agents Ch – volume: 17 start-page: 704 year: 2011 end-page: 711 article-title: Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in from cystic fibrosis patients publication-title: Clin Microbiol Infec – volume: 62 start-page: 830 year: 2008 end-page: 836 article-title: Antibiotic consumption in southern and eastern Mediterranean hospitals publication-title: results from the ARMed project – start-page: 1 year: 1997 end-page: 14 – volume: 26 start-page: 1 year: 1998 end-page: 10 article-title: Pharmacokinetic/pharmacodynamic parameters publication-title: rationale for antibacterial dosing of mice and men – volume: 47 start-page: 1023 year: 2003 end-page: 1027 article-title: Mutant prevention concentration of garenoxacin (BMS‐284756) for ciprofloxacin‐susceptible or ‐resistant publication-title: Antimicrob Agents Ch – volume: 34 start-page: 499 year: 2002 ident: 2016041923103206000_35.5.977.108 article-title: Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites publication-title: Clin Infect Dis doi: 10.1086/338639 contributor: fullname: Rahal – volume: 65 start-page: 1842 year: 2010 ident: 2016041923103206000_35.5.977.118 article-title: The 2009 Garrod lecture: the evolution of antimicrobial resistance: a Darwinian perspective publication-title: J Antimicrob Chemoth doi: 10.1093/jac/dkq217 contributor: fullname: Sykes – ident: 2016041923103206000_35.5.977.122 doi: 10.1093/jac/dkr053 – ident: 2016041923103206000_35.5.977.107 doi: 10.1007/s00431-008-0901-0 – volume: 10 start-page: 481 year: 2007 ident: 2016041923103206000_35.5.977.40 article-title: Expanding the soil antibiotic resistome: exploring environmental diversity publication-title: Curr Opin Microbiol doi: 10.1016/j.mib.2007.08.009 contributor: fullname: D'Costa – volume: 67 start-page: 27 year: 2001 ident: 2016041923103206000_35.5.977.45 article-title: A strategy for fighting antibiotic resistance publication-title: ASM News contributor: fullname: Drlica – volume: 54 start-page: 178 year: 2004 ident: 2016041923103206000_35.5.977.51 article-title: ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model publication-title: J Antimicrob Chemoth doi: 10.1093/jac/dkh242 contributor: fullname: Firsov – volume: 6 start-page: e1000735 year: 2010 ident: 2016041923103206000_35.5.977.97 article-title: Evolutionary trajectories of β-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1000735 contributor: fullname: Novais – volume: 28 start-page: S115 issue: (suppl 2) year: 2006 ident: 2016041923103206000_35.5.977.27 article-title: Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin publication-title: Int J Antimicrob Ag doi: 10.1016/j.ijantimicag.2006.06.001 contributor: fullname: Cantón – volume: 35 start-page: 316 year: 2010 ident: 2016041923103206000_35.5.977.104 article-title: Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4 publication-title: Int J Antimicrob Ag doi: 10.1016/j.ijantimicag.2009.11.003 contributor: fullname: Peirano – ident: 2016041923103206000_35.5.977.72 – ident: 2016041923103206000_35.5.977.128 doi: 10.1164/rccm.200401-070OC – ident: 2016041923103206000_35.5.977.89 doi: 10.1016/S0958-1669(03)00036-3 – volume: 191 start-page: 44 year: 2009 ident: 2016041923103206000_35.5.977.111 article-title: The Pseudomonas aeruginosapfpI gene plays an antimutator role and provides general stress protection publication-title: J Bacteriol doi: 10.1128/JB.01081-08 contributor: fullname: Rodríguez-Rojas – ident: 2016041923103206000_35.5.977.67 doi: 10.1093/jac/dkg312 – ident: 2016041923103206000_35.5.977.23 – volume: 62 start-page: 830 year: 2008 ident: 2016041923103206000_35.5.977.20 article-title: Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project publication-title: J Antimicrob Chemoth doi: 10.1093/jac/dkn260 contributor: fullname: Borg – volume: 40 start-page: 503 year: 1996 ident: 2016041923103206000_35.5.977.28 article-title: Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis publication-title: Antimicrob Agents Ch doi: 10.1128/AAC.40.2.503 contributor: fullname: Carratalà – ident: 2016041923103206000_35.5.977.62 doi: 10.1016/j.ijantimicag.2009.12.011 – ident: 2016041923103206000_35.5.977.73 doi: 10.1146/annurev.micro.112408.134306 – volume: 55 start-page: 6 year: 2005 ident: 2016041923103206000_35.5.977.24 article-title: Antibiotic cycling or rotation: a systematic review of the evidence of efficacy publication-title: J Antimicrob Chemoth doi: 10.1093/jac/dkh482 contributor: fullname: Brown – ident: 2016041923103206000_35.5.977.17 doi: 10.1128/AAC.44.8.2182-2184.2000 – ident: 2016041923103206000_35.5.977.116 doi: 10.2174/092986708786848442 – ident: 2016041923103206000_35.5.977.49 doi: 10.1128/AAC.00156-07 – volume: 15 start-page: 647 year: 2002 ident: 2016041923103206000_35.5.977.83 article-title: Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance publication-title: Clin Microbiol Rev doi: 10.1128/CMR.15.4.647-679.2002 contributor: fullname: Martínez – volume: 26 start-page: 1 year: 1998 ident: 2016041923103206000_35.5.977.35 article-title: Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men publication-title: Clin Infect Dis doi: 10.1086/516284 contributor: fullname: Craig – volume: 64 start-page: 83 year: 2007 ident: 2016041923103206000_35.5.977.76 article-title: Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli publication-title: Mol Microbiol doi: 10.1111/j.1365-2958.2007.05642.x contributor: fullname: López – ident: 2016041923103206000_35.5.977.81 doi: 10.1128/JB.00549-08 – volume: 68 start-page: 20 year: 2010 ident: 2016041923103206000_35.5.977.125 article-title: Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2010.04.008 contributor: fullname: Valderrey – ident: 2016041923103206000_35.5.977.90 doi: 10.3201/eid1008.020694 – ident: 2016041923103206000_35.5.977.66 – ident: 2016041923103206000_35.5.977.121 doi: 10.1016/j.idc.2010.11.011 – volume: 15 start-page: 167 year: 2002 ident: 2016041923103206000_35.5.977.43 article-title: Biofilms: survival mechanisms of clinically relevant microorganisms publication-title: Clin Microbiol Rev doi: 10.1128/CMR.15.2.167-193.2002 contributor: fullname: Donlan – ident: 2016041923103206000_35.5.977.133 doi: 10.1128/AAC.47.3.1023-1027.2003 – volume: 156 start-page: 1108 year: 2010 ident: 2016041923103206000_35.5.977.32 article-title: Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants publication-title: Microbiology doi: 10.1099/mic.0.033993-0 contributor: fullname: Ciofu – ident: 2016041923103206000_35.5.977.84 doi: 10.1086/593186 – volume: 26 start-page: 43 year: 2005 ident: 2016041923103206000_35.5.977.65 article-title: Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents publication-title: Int J Antimicrob Ag doi: 10.1016/j.ijantimicag.2005.04.007 contributor: fullname: Hsueh – ident: 2016041923103206000_35.5.977.11 doi: 10.1007/978-1-59745-180-2_2 – volume: 6 start-page: 725 year: 2008 ident: 2016041923103206000_35.5.977.102 article-title: Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications publication-title: Expert Rev Anti Infect Ther doi: 10.1586/14787210.6.5.725 contributor: fullname: Pallecchi – ident: 2016041923103206000_35.5.977.126 doi: 10.1128/JCM.42.10.4769-4775.2004 – ident: 2016041923103206000_35.5.977.44 doi: 10.1093/jac/dkn044 – ident: 2016041923103206000_35.5.977.19 doi: 10.1128/AAC.45.2.433-438.2001 – volume: 44 start-page: 2581 year: 2000 ident: 2016041923103206000_35.5.977.42 article-title: Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis publication-title: Antimicrob Agents Ch doi: 10.1128/AAC.44.9.2581-2584.2000 contributor: fullname: Dong – ident: 2016041923103206000_35.5.977.130 doi: 10.1128/JB.01581-07 – volume: 14 start-page: 107 year: 2011 ident: 2016041923103206000_35.5.977.93 article-title: Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective publication-title: Drug Resist Update doi: 10.1016/j.drup.2011.02.005 contributor: fullname: Mouton – ident: 2016041923103206000_35.5.977.54 doi: 10.1111/j.1469-0691.2010.03317.x – ident: 2016041923103206000_35.5.977.31 doi: 10.1128/AAC.00736-05 – ident: 2016041923103206000_35.5.977.60 doi: 10.1046/j.1365-2958.1999.01672.x – ident: 2016041923103206000_35.5.977.78 doi: 10.1093/jac/dkn357 – ident: 2016041923103206000_35.5.977.80 doi: 10.1111/j.1469-0691.2006.01592.x – volume: 19 start-page: 323 year: 2002 ident: 2016041923103206000_35.5.977.92 article-title: Breakpoints: current practice and future perspectives publication-title: Int J Antimicrob Ag doi: 10.1016/S0924-8579(02)00028-6 contributor: fullname: Mouton – ident: 2016041923103206000_35.5.977.109 doi: 10.1586/14787210.6.5.671 – ident: 2016041923103206000_35.5.977.117 doi: 10.1093/jac/dkp387 – volume: 57 start-page: 1116 year: 2006 ident: 2016041923103206000_35.5.977.101 article-title: Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration publication-title: J Antimicrob Chemoth doi: 10.1093/jac/dkl135 contributor: fullname: Olofsson – volume: 54 start-page: 640 year: 2004 ident: 2016041923103206000_35.5.977.37 article-title: In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants publication-title: J Antimicrob Chemoth doi: 10.1093/jac/dkh393 contributor: fullname: Croisier – ident: 2016041923103206000_35.5.977.64 doi: 10.1016/j.ijantimicag.2005.08.016 – ident: 2016041923103206000_35.5.977.21 doi: 10.1016/j.ajic.2009.07.010 – ident: 2016041923103206000_35.5.977.106 doi: 10.1086/422647 – ident: 2016041923103206000_35.5.977.74 doi: 10.1101/cshperspect.a000398 – volume: 1 start-page: 295 year: 1998 ident: 2016041923103206000_35.5.977.13 article-title: Selection of very small differences in bacterial evolution publication-title: Int Microbiol contributor: fullname: Baquero – ident: 2016041923103206000_35.5.977.38 doi: 10.1086/508752 – ident: 2016041923103206000_35.5.977.18 doi: 10.1111/j.1365-2958.2006.05366.x – volume: 32 start-page: 488 year: 2008 ident: 2016041923103206000_35.5.977.52 article-title: Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion publication-title: Int J Antimicrob Ag doi: 10.1016/j.ijantimicag.2008.06.031 contributor: fullname: Firsov – volume: 14 start-page: R113 year: 2010 ident: 2016041923103206000_35.5.977.87 article-title: Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008 publication-title: Crit Care doi: 10.1186/cc9062 contributor: fullname: Meyer – ident: 2016041923103206000_35.5.977.47 – ident: 2016041923103206000_35.5.977.14 doi: 10.1007/BF01716300 – ident: 2016041923103206000_35.5.977.105 doi: 10.1128/AAC.00174-07 – ident: 2016041923103206000_35.5.977.127 doi: 10.1128/JCM.01008-08 – ident: 2016041923103206000_35.5.977.50 doi: 10.1128/AAC.01347-08 – volume: 54 start-page: 3414 year: 2010 ident: 2016041923103206000_35.5.977.71 article-title: Population dynamics of antibiotic treatment: a mathematical model and hypotheses for time-kill and continuous-culture experiments publication-title: Antimicrob Agents Ch doi: 10.1128/AAC.00381-10 contributor: fullname: Levin – ident: 2016041923103206000_35.5.977.113 doi: 10.1111/j.1749-6632.2010.05788.x – ident: 2016041923103206000_35.5.977.75 doi: 10.1128/AAC.00358-09 – ident: 2016041923103206000_35.5.977.33 – ident: 2016041923103206000_35.5.977.94 doi: 10.1128/JB.01651-09 – ident: 2016041923103206000_35.5.977.55 doi: 10.1093/jac/dkm186 – volume: 31 start-page: 277 year: 1999 ident: 2016041923103206000_35.5.977.6 article-title: Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences publication-title: J Hepatol doi: 10.1016/S0168-8278(99)80225-6 contributor: fullname: Aparicio – ident: 2016041923103206000_35.5.977.48 doi: 10.1086/600122 – ident: 2016041923103206000_35.5.977.82 doi: 10.1128/AAC.00428-08 – volume: 2 start-page: 95 year: 2004 ident: 2016041923103206000_35.5.977.57 article-title: Bacterial biofilms: from the natural environment to infectious diseases publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro821 contributor: fullname: Hall-Stoodley – ident: 2016041923103206000_35.5.977.12 doi: 10.1002/bies.950190814 – ident: 2016041923103206000_35.5.977.46 doi: 10.1016/S0140-6736(00)04519-0 – volume: 4 start-page: 93 year: 2001 ident: 2016041923103206000_35.5.977.8 article-title: Low-level antibacterial resistance: a gateway to clinical resistance publication-title: Drug Resist Update doi: 10.1054/drup.2001.0196 contributor: fullname: Baquero – ident: 2016041923103206000_35.5.977.77 doi: 10.1089/mdr.2010.0074 – ident: 2016041923103206000_35.5.977.98 doi: 10.1111/j.1469-0691.2010.03250.x – ident: 2016041923103206000_35.5.977.2 doi: 10.1073/pnas.1018588108 – ident: 2016041923103206000_35.5.977.103 doi: 10.1016/j.vetmic.2006.08.018 – ident: 2016041923103206000_35.5.977.61 doi: 10.1016/j.tiv.2005.08.004 – volume: 31 start-page: 664 year: 2010 ident: 2016041923103206000_35.5.977.53 article-title: Correlation between rates of carbapenem consumption and the prevalence of carbapenem-resistant Pseudomonas aeruginosa in a tertiary care hospital in Brazil: a 4-year study publication-title: Infect Control Hosp Epidemiol doi: 10.1086/653071 contributor: fullname: Furtado – ident: 2016041923103206000_35.5.977.4 doi: 10.1111/j.1574-6976.2011.00289.x – ident: 2016041923103206000_35.5.977.30 doi: 10.1016/S1368-7646(03)00041-4 – ident: 2016041923103206000_35.5.977.1 doi: 10.4161/viru.2.2.15014 – ident: 2016041923103206000_35.5.977.3 doi: 10.1146/annurev-genet-102108-134805 – volume: 66 start-page: 1659 year: 2011 ident: 2016041923103206000_35.5.977.10 article-title: The 2010 Garrod Lecture: the dimension of evolution in antibiotic resistance: ex unibus plurum et ex pluribus unum publication-title: J Antimicrob Chemoth doi: 10.1093/jac/dkr214 contributor: fullname: Baquero – volume: 51 start-page: 744 year: 2007 ident: 2016041923103206000_35.5.977.120 article-title: The relationship between quinolone exposures and resistance amplification is characterized by an inverted U: a new paradigm for optimizing pharmacodynamics to counterselect resistance publication-title: Antimicrob Agents Ch doi: 10.1128/AAC.00334-06 contributor: fullname: Tam – volume: 192 start-page: 420 year: 2005 ident: 2016041923103206000_35.5.977.119 article-title: Bacterial-population responses to drug-selective pressure: examination of garenoxacin's effect on Pseudomonas aeruginosa publication-title: J Infect Dis doi: 10.1086/430611 contributor: fullname: Tam – ident: 2016041923103206000_35.5.977.123 doi: 10.1093/jac/dkq496 – volume: 43 start-page: 1756 year: 1999 ident: 2016041923103206000_35.5.977.41 article-title: Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus publication-title: Antimicrob Agents Ch doi: 10.1128/AAC.43.7.1756 contributor: fullname: Dong – ident: 2016041923103206000_35.5.977.99 doi: 10.1126/science.288.5469.1251 – ident: 2016041923103206000_35.5.977.100 doi: 10.1111/j.1574-6968.2002.tb11452.x – ident: 2016041923103206000_35.5.977.85 doi: 10.1016/S0924-8579(10)70005-4 – ident: 2016041923103206000_35.5.977.131 doi: 10.1128/AAC.01620-05 – ident: 2016041923103206000_35.5.977.34 doi: 10.1111/j.1574-6976.2009.00165.x – ident: 2016041923103206000_35.5.977.69 doi: 10.1086/502304 – ident: 2016041923103206000_35.5.977.86 doi: 10.1007/s00134-008-1355-6 – volume: 2 start-page: 510 year: 2004 ident: 2016041923103206000_35.5.977.9 article-title: From pieces to patterns: evolutionary engineering in bacterial pathogens publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro909 contributor: fullname: Baquero – ident: 2016041923103206000_35.5.977.22 doi: 10.1128/AAC.00927-10 – ident: 2016041923103206000_35.5.977.68 doi: 10.1016/j.molcel.2010.01.003 – ident: 2016041923103206000_35.5.977.59 doi: 10.1016/j.ijantimicag.2005.10.005 – ident: 2016041923103206000_35.5.977.58 doi: 10.1179/joc.2005.17.5.484 – ident: 2016041923103206000_35.5.977.79 doi: 10.1128/AAC.49.8.3382-3386.2005 – ident: 2016041923103206000_35.5.977.129 doi: 10.1016/j.ijantimicag.2011.02.002 – ident: 2016041923103206000_35.5.977.91 doi: 10.1128/AAC.00155-06 – ident: 2016041923103206000_35.5.977.112 doi: 10.1056/NEJM199708143370701 – ident: 2016041923103206000_35.5.977.16 doi: 10.1086/378810 – volume: 13 start-page: 19035 year: 2008 ident: 2016041923103206000_35.5.977.5 article-title: Recent trends in antimicrobial resistance among Streptococcus pneumoniae and Staphylococcus aureus isolates: the French experience publication-title: Euro Surveill – ident: 2016041923103206000_35.5.977.96 doi: 10.1128/AAC.38.1.122 – ident: 2016041923103206000_35.5.977.132 doi: 10.1093/jac/dkn229 – ident: 2016041923103206000_35.5.977.29 doi: 10.1111/j.1469-0691.2010.03349.x – ident: 2016041923103206000_35.5.977.124 doi: 10.1128/CMR.00047-06 – ident: 2016041923103206000_35.5.977.39 doi: 10.1126/science.1120800 – ident: 2016041923103206000_35.5.977.110 doi: 10.1128/AAC.01444-06 – ident: 2016041923103206000_35.5.977.115 doi: 10.1099/mic.0.26751-0 – ident: 2016041923103206000_35.5.977.36 doi: 10.1128/AAC.01353-09 – ident: 2016041923103206000_35.5.977.56 doi: 10.1086/648451 – volume: 66 start-page: 1 year: 2010 ident: 2016041923103206000_35.5.977.70 article-title: Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2009.08.014 contributor: fullname: Lepelletier – volume: 16 start-page: 315 year: 2003 ident: 2016041923103206000_35.5.977.25 article-title: Multi-resistant Gram-negative bacilli: from epidemics to endemics publication-title: Curr Opin Infect Dis doi: 10.1097/00001432-200308000-00003 contributor: fullname: Cantón – ident: 2016041923103206000_35.5.977.15 doi: 10.1086/598345 – ident: 2016041923103206000_35.5.977.95 doi: 10.1128/AAC.44.9.2485-2491.2000 – ident: 2016041923103206000_35.5.977.63 doi: 10.1128/AAC.01372-06 – ident: 2016041923103206000_35.5.977.26 – ident: 2016041923103206000_35.5.977.88 doi: 10.7326/0003-4819-119-5-199309010-00001 – volume: 1213 start-page: 81 year: 2010 ident: 2016041923103206000_35.5.977.7 article-title: Antibiotic heterogeneity: from concept to practice publication-title: Ann NY Acad Sci doi: 10.1111/j.1749-6632.2010.05867.x contributor: fullname: Bal – ident: 2016041923103206000_35.5.977.114 doi: 10.1111/j.1469-0691.2005.01211.x |
| SSID | ssj0005955 |
| Score | 2.522914 |
| SecondaryResourceType | review_article |
| Snippet | Abstract
Within a susceptible wild-type population, a small fraction of cells, even <10−9, is not affected when challenged by an antimicrobial agent. This... Within a susceptible wild‐type population, a small fraction of cells, even <10−9, is not affected when challenged by an antimicrobial agent. This subpopulation... Within a susceptible wild-type population, a small fraction of cells, even <10(-9) , is not affected when challenged by an antimicrobial agent. This... Within a susceptible wild-type population, a small fraction of cells, even <10(-9) , is not affected when challenged by an antimicrobial agent. This... Within a susceptible wild-type population, a small fraction of cells, even <10-9, is not affected when challenged by an antimicrobial agent. This subpopulation... |
| SourceID | proquest crossref pubmed wiley oup |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 977 |
| SubjectTerms | Anti-Bacterial Agents - pharmacokinetics Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Bacteria - drug effects Bacteria - genetics Bacterial Infections - drug therapy Bacterial Infections - microbiology Drug Resistance, Bacterial Gene Transfer, Horizontal horizontal gene transfer Humans mutant prevention concentration mutant selection window Mutation quinolone resistance resistant mutants Selection, Genetic Time Factors β‐lactam resistance |
| Title | Emergence and spread of antibiotic resistance following exposure to antibiotics |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1574-6976.2011.00295.x https://www.ncbi.nlm.nih.gov/pubmed/21722146 https://search.proquest.com/docview/880716864 https://search.proquest.com/docview/902364974 |
| Volume | 35 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1Na9swVKQtg13GvpfuAx12nECWZTs6tqtDd9gGW1d6M7IlQQ-zQ52w7t_36cOWMxrIBsvBBOXJTt57eXrfD6H3XFFFJeNEUmYI501Nakk5qUXOFyY3tXSFtOffiy9Xi7OSl7PZMBMvrv1XSsMa0NpWzv4FtcebwgK8B5rDFagO173oXoZ6Sh8W6FegFCoX7G9tdUjnWzb3Vmu0MAbYoPtl3QX6dtVZb6FVRiNsP1VelyVY_T-vJ62bQi_TGMho1zbyfpp6y16aISPfp_V2_bWbIGUrhFyE_kyOyRafelkHYBW9qmLqhPjD2eidZzEtyTku8wUB3ctHsHUQtgUnufDzXwZp7JuXBK7LJqJVhHEv_pQWfsbX7gNguHfo0kqZyIbE0GnP7XFPtu8ud_YvP3-Djw7QEQP5BuL16OT06vIy5haJzOfOhh-9nUJ270O29KKtWsuJybNtQTkV6OIxehRsF3zime4Jmun2KXrgp5n-foa-jqyHgfWwZz3cGRzZCUfWwyPr4YH18LqbwPbP0Y9lefHxnIR5HaQBuzQjohBKpZntCZkoppgB6w3MBc6KptFcc3glOdWFoNTQxnApuNGZBBU1TZU0afoCHbZdq18hbHSjQNG3MfecJ1TVWiW8UcZqpwVnbI6SAVvVyrdlqSbmLGC4shiuLIYrh-Hqdo4-AFp3gJN7wPGA_wpEro2jyVZ3m76CI68AyuZ8N4hwgxnAVp-jl55043PtRDgG-skcZY6We3__yjPd8T_ue40exn_uG3S4vtnot-igV5t3gX3vAB3FvGc |
| link.rule.ids | 315,782,786,27933,27934 |
| linkProvider | Oxford University Press |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Emergence+and+spread+of+antibiotic+resistance+following+exposure+to+antibiotics&rft.jtitle=FEMS+microbiology+reviews&rft.au=Cant%C3%B3n%2C+Rafael&rft.au=Morosini%2C+Mar%C3%ADa%E2%80%90Isabel&rft.date=2011-09-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0168-6445&rft.eissn=1574-6976&rft.volume=35&rft.issue=5&rft.spage=977&rft.epage=991&rft_id=info:doi/10.1111%2Fj.1574-6976.2011.00295.x&rft.externalDBID=10.1111%252Fj.1574-6976.2011.00295.x&rft.externalDocID=FMR295 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-6445&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-6445&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-6445&client=summon |